ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 219 | -93.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 3,117 | +528.4% | 0.00% | – |
| Q2 2018 | $0 | – | 496 | +185.1% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 174 | -96.6% | 0.00% | – |
| Q4 2017 | $12,000 | +200.0% | 5,183 | +297.2% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 1,305 | -4.3% | 0.00% | – |
| Q2 2017 | $5,000 | +66.7% | 1,363 | +50.8% | 0.00% | – |
| Q1 2017 | $3,000 | -83.3% | 904 | -76.7% | 0.00% | – |
| Q4 2016 | $18,000 | +500.0% | 3,880 | +475.7% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 674 | -5.7% | 0.00% | – |
| Q2 2016 | $2,000 | -84.6% | 715 | -74.5% | 0.00% | – |
| Q1 2016 | $13,000 | +30.0% | 2,806 | +8.8% | 0.00% | – |
| Q4 2015 | $10,000 | +400.0% | 2,580 | +482.4% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 443 | -34.6% | 0.00% | – |
| Q2 2015 | $3,000 | -90.9% | 677 | -86.2% | 0.00% | – |
| Q1 2015 | $33,000 | +200.0% | 4,907 | +46.5% | 0.00% | – |
| Q4 2014 | $11,000 | – | 3,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
| Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
| WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
| Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
| BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
| Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |